Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;37(8):e14992.
doi: 10.1111/ctr.14992. Epub 2023 Apr 19.

The first 10 years of simultaneous pancreas-kidney transplantation in Finland

Kaisa Ahopelto  1 , Ville Sallinen  1 , Ilkka Helanterä  1 , Akseli Bonsdorff  1 , Juulia Grasberger  2 , Ines Beilmann-Lehtonen  1 , Heikki Mäkisalo  1 , Arno Nordin  1 , Fernanda Ortiz  2 , Johanna Savikko  1 , Eija Tukiainen  1 , Aki Uutela  1 , Agneta Ekstrand  2 , Marko Lempinen  1
Affiliations

The first 10 years of simultaneous pancreas-kidney transplantation in Finland

Kaisa Ahopelto et al. Clin Transplant. 2023 Aug.

Abstract

Introduction: Simultaneous pancreas-kidney transplantation (SPK) is an option for patients with type 1 diabetes (T1D) and kidney failure but can be associated with a high complication rate. Here we describe our 10-year experience since the launch of the SPK program.

Methods: This retrospective study included consecutive patients with T1D receiving SPK from March 14, 2010 to March 14, 2020 at Helsinki University Hospital. Portocaval anastomosis (i.e., systemic venous drainage) and enteric exocrine drainage were used. A specific team was trained for both pancreas retrieval and transplantation, postoperative care was standardized to include somatostatin analogues, antimicrobial treatment, and preoperatively initiated chemothrombopropylaxis. During program maturation donor criteria were expanded and logistical processes improved to minimize cold ischemia time. Clinical data were collected from a nationwide transplantation registry and patient records.

Results: A total of 166 SPKs were performed (median 2 per year in the first 3 years, 17.5 per year for the following 4 years, and 23 per year for the past 3 years). Seven patients (4.1%) died with a functioning graft with a median 43 months follow-up. One-year pancreas graft survival was 97.0%, 3-year pancreas graft survival was 96.1% and 5-year was 96.1%. Mean HbA1c was 36 mmol/mol (SD 5.57) and creatinine was 107 μmol/L (SD 34.69) at 1-year after transplantation. All kidney grafts were functioning at the end of follow-up. Complications required re-laparotomy in 39 (23%) patients, mostly due to a pancreas graft related problem (N = 28). No pancreas or kidney graft failure from thrombosis occurred.

Conclusion: A planned, step-wise development of an SPK program offers a safe and effective treatment for patients with T1D and kidney failure.

Keywords: complications; graft thrombosis; pancreas transplantation; simultaneous pancreas-kidney transplantation.

PubMed Disclaimer

References

REFERENCES

    1. Esmeijer K, Hoogeveen EK, Van Den Boog PJM, et al. Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replacement therapy: 30-year follow-up of a nationwide cohort. Diab Care. 2020;43(2):321-328. doi: 10.2337/dc19-1580
    1. Xue W, Huang Z, Zhang Y, Hu X. Patient, kidney, and pancreas survival in pancreas after kidney transplantation versus simultaneous pancreas and kidney transplantation: meta-analysis. BJS Open. 2022;6(5), zrac108. doi: 10.1093/bjsopen/zrac108
    1. Posegger KR, Linhares MM, Mucci S, et al. The quality of life in type I diabetic patients with end-stage kidney disease before and after simultaneous pancreas-kidney transplantation: a single-center prospective study. Transp Int. 2020;33(3):330-339. doi: 10.1111/tri.13562
    1. Bonsdorff A, Sallinen V, Räihä J, et al. First-day plasma amylase detects patients at risk of complications after simultaneous pancreas-kidney transplantation. Clin Transplant. 2021;35(4). doi: 10.1111/ctr.14233
    1. Knip M. Type 1 diabetes in Finland: past, present, and future. Lancet Diab Endocrinol. 2021;9(5):259-260. doi: 10.1016/S2213-8587(21)00074-7

LinkOut - more resources